Chinese expert consensus on clinical application of molecularly targeted drugs for hepatocellular carcinoma (2022 edition).
Sun J, Li Q, Bai X, Cai J, Chen Y, Chen M, Dai C, Fang C, Jia W, Li X, Wen T, Xia J, Ying M, Zhang Z, Zhang X, Zeng Z, Cheng S; Chinese Association of Liver Cancer and Chinese Medical Doctor Association.
Sun J, et al. Among authors: wen t.
Chin Med J (Engl). 2024 Sep 23. doi: 10.1097/CM9.0000000000003301. Online ahead of print.
Chin Med J (Engl). 2024.
PMID: 39307924
No abstract available.